🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Super présentation sur les inhibiteurs proximaux en première ligne pour #hpn @eha2024 CHU de Nice

CONGRESS | POSTER | #EHA2024 | Thomas Cluzeau CHU de Nice reports results from the ATHENA study describing real-world utilization of blinatumomab in adult and pediatric patients with ALL in France. Four key uses of blinatumomab were identified: HSCT preparation, adults (31.3%),

Want to hear about how to approach patients with TP53-mutated MDS and secondary AML?💭 Watch our discussion from #iwMDS24, in which leading experts @ColemanLindsley, David Sallman, & Thomas Cluzeau share their insights: 👉 ow.ly/FEWX50SHZFb #MDSsm #AMLsm #Leusm #HemOnc

A massive thank you to Harry Erba (Duke Cancer), Farhad Ravandi (MD Anderson Cancer Center), and Thomas Cluzeau for sharing their insights into prolonging remission in AML! Check out our most recent session: 👉ow.ly/xXLV50TeABO👈 #AMLsm #Leusm #Leukemia #HemOnc

Key opinion leaders summarize their main takeaways from #EHA24 regarding advances in lower-risk myelodysplastic syndrome treatment. G Garcia-Manero Rami komrokji Amer Zeidan MBBS,MHS ‏عامر زيدان Thomas Cluzeau Yale School of Medicine Moffitt Cancer Center MD Anderson Cancer Center #hematology onclive.com/view/final-tho…

Great talk by Dr Cluzeau Thomas Cluzeau about a difficult topic: TP53 treatment options 👏🏼👏🏼Thomas @sehh_es

Máximo interés en el Simposio que aborda de forma profunda aspectos diagnósticos, pronósticos y clínicos de neoplasias hematológicas @sehh_es #Hemato2024: Neoplasias mieloides con mutación de TP53. Moderadores:Dr Raya y Dra Prats Ponentes:Dra Guijarro, Dra Calasanz y Dr Cluzeau.

Great Italian French collaboration: Long-term real world evidence of CPX-351 of high-risk AML patients identified high rate of negative MRD and prolonged OS ashpublications.org/bloodadvances/…

In a wonderful joint discussion from #iwAL24, experts Richard Stone, Marina Konopleva, & Thomas Cluzeau speak on novel treatments & combinations in AML, commenting on mechanisms of resistance to venetoclax & approaching R/R disease: 🎥 ow.ly/HzFR50U5ZLk #Leusm #AMLsm #HemOnc

Spotlight on: Prolonging #Remission In Patients With #AML 🗞️🩸 ✓ The implications of front-line therapy in AML ✓ The role and utilization of #transplantation in AML ✓ Updates in treatments to prolong #remission Take a look 👉 vjhemonc.com/feature/spotli…

Le service d’#hematologie du CHU de Nice grâce au Dr Loschi: Pionnier de l’utilisation thérapeutique du microbiote. Hacking the Microbiome to Fight Cancer youtu.be/P8pd0TlITpo?si… via YouTube Bloomberg TV

[Recherche] 🔬 🎉Félicitations au Pr Thomas Cluzeau du CHU de Nice pour sa recherche d' #excellence : publié dans la revue : #Blood advances "Long-term real world evidence of CPX-351 of high-risk AML patients identified high rate of negative MRD and prolonged OS"

L’#Hematologie du CHU de Nice bien représenté au congrès #mao à Monaco. Brillantes présentations des Dr Richez #myelome, Dr Chiche #lymphome et Dr Loschi #cart

Newsletter de la recherche clinique en #hematologie CHU de Nice #innovation #clip #leucemie #myelome #lymphome #cart

#ESH #MPN Vienne. Dr Loschi from the Hematology Department CHU de Nice presented the results and perspectives of Selinexor combos in the first Line treatment of #Myelofibrosis patients

It was great speaking with Michael Loschi of CHU de Nice to hear about a session on combination therapy in #myelofibrosis at the recent #ESHCMLMPN2025 meeting. Click here to watch the interview: 👉 ow.ly/kh8j50VkB4k 👈 #MPNsm #HemOnc ESH (Haematology)

Very proud to participate with @matteodellaporta and Amer Zeidan MBBS,MHS ‏عامر زيدان at this #mds #BMS symposium MDS Foundation 2025

6eme post EHA régional PACA-Est et Monaco CHU de Nice en collaboration avec Hôpital d'Antibes #lam #lal #lnh #myelome #smd #smp #llc danielre

Congrats Dr Michael Loschi for the presentation of results of a national study on #transplantation of #DDX41 mutated #AML patients EHA CHU de Nice

Very proud to chair with Amer Zeidan MBBS,MHS ‏عامر زيدان and present on #TP53 #MDS #AML at #IwMDSMPN25